The Organising committee of the Evolutionary Melanoma Conference has made the difficult decision, after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to postpone the conference, originally scheduled for the 8-9 May 2020 in Limassol, Cyprus. A rescheduled meeting is being planned for early next year.
The Committee has been closely monitoring the rapidly increasing domestic and worldwide developments during the last several weeks related to COVID-19. This evidence-based decision was made after a thorough review of and discussion concerning all factors which impact the Conference. These include the Republic of Cyprus’ enforcement of restrictions on international travelers entering Cyprus, and the opinion of the Counsel of Infectious Disease experts. It is clear that all of these elements significantly affect the ability of delegates, speakers, presenters of proffered papers, and exhibitors to participate fully in the Conference.
The health, safety, and security of all Conference attendees are the Organizing Committee’s highest priorities. Whilst we believe that the decision to postpone the meeting is absolutely the correct one in order to safeguard our participants from further potential exposure to the coronavirus, we also understand that this is disappointing for our sponsors. We recognize that the presentation of new data, exchange of information, and opportunities for collaboration offered by the Conference are highly valued by the entire cancer research community, and we are investigating options for rescheduling the Conference as soon as possible.
We thank all of our sponsors for their patience and support at this time. We will announce the dates and location of the rescheduled Evolutionary Melanoma Conference 2020 as soon as they are confirmed. Our heartfelt sympathies go out to everyone impacted by this global health crisis.